Dihexa 30 Tablets

Researchers investigate Dihexa within controlled laboratory environments to examine compound stability and molecular mechanisms. Experimental models utilize this tablet format to study compound characteristics in vitro. Controlled laboratory stability studies assess tablet properties under standardized experimental conditions. Scientists explore formulation characteristics and compound stability in tablet format. Laboratory personnel examine tablet-form compound behavior in experimental models designed for formulation research. These investigations occur exclusively in controlled research environments without clinical applications.

Dihexa is investigated in research environments to understand molecular interaction mechanisms. This compound is studied within controlled laboratory models examining cellular pathway properties. Researchers explore this compound for experimental research applications in academic settings. Laboratory studies examine the compound’s characteristics under standardized protocols. Scientists investigate molecular properties relevant to research methodologies. All research applications remain confined to laboratory environments and experimental frameworks.

Store Dihexa tablets in cool, dry conditions protected from light exposure. Storage temperature should remain consistent to maintain tablet stability. Keep tablets in original packaging until ready for laboratory use. Laboratory handling should occur only by qualified research personnel trained in compound research protocols. Avoid exposure to moisture, heat, and direct sunlight during storage. Use appropriate laboratory equipment when handling these research tablets. Tablets should be stored in their sealed container to prevent moisture absorption. Maintain proper documentation of handling and storage conditions for research records. Dispose of unused material according to institutional laboratory waste protocols.

Each batch undergoes comprehensive purity verification procedures to confirm research-grade quality. Third-party testing validates compound content and tablet uniformity across the batch. Batch-to-batch consistency ensures reliable results across research protocols. Certificate of Analysis accompanies each order documenting purity verification and tablet specifications. Internal quality assurance standards maintain strict formulation specifications. Testing procedures verify compound content, tablet weight uniformity, and molecular identity. Research-grade supply positioning ensures suitability for controlled laboratory investigations. Quality control documentation supports institutional research compliance requirements.

• CAS: 1401708-83-5
• Chemical Formula: C₂₇H₄₄N₄O₅
• Molecular Weight: 504.66 g/mol
• Peptide Sequence: Hexanoyl-Tyr-Ile-Unk (N-Hexanoyl-L-tyrosyl-N-(6-amino-6-oxohexyl)-L-isoleucinamide
• Synonyms: PNB-0408, fosgonimeto
• Shelf life: 24 months from the manufacturing date.

Dihexa is a synthetic compound produced for research applications. A synthetic compound is a laboratory-created molecule with a specific chemical structure. This tablet formulation contains 8 milligrams of the compound per unit. Tablets are solid formulations that contain the active compound in a stable form. This format provides researchers with pre-measured units for standardized experimental protocols. The compound consists of a defined molecular structure designed for laboratory investigation. Researchers examine this tablet formulation’s properties within controlled laboratory conditions without therapeutic context.

This synthetic research compound formulation provides laboratories with pre-measured tablet units for experimental studies. The 8mg tablet format delivers thirty standardized units for consistent research applications. Each batch undergoes rigorous purity verification to ensure consistency across research protocols. High-purity formulation meets research-grade standards for tablet-form compound investigations. Secure packaging protects tablet integrity during storage and transport. Discreet shipment ensures confidential delivery to research facilities and institutional laboratories.